Comparison of genicular nerve block and its combination with IPACK block for analgesia and recovery after total knee arthroplasty: a randomized trial Authors: Heba M. Fathi, Ahmed M. Fahmy, Michael Adel Shaker, Alshaimaa Abdel Fattah Kamel Published: 2025 ABSTRACT BackgroundOptimal analgesia is the cornerstone for enhanced recovery following total knee arthroplasty (TKA). The present study was conducted to assess the additive effect of Infiltration between Popliteal Artery and Capsule of Posterior Knee (IPACK) to Genicular Nerve Block (GNB) block compared to GNB alone. The primary outcome was Visual analogue scale (VAS) scores at 8 h with mobility postoperative and secondary outcomes include VAS scores at 2, 4, 6, 12, 18 & 24 h at rest and motion postoperative, duration to first rescue analgesia (morphine) 24 h postoperative, total morphine consumption at 1st 24 h postoperative, functional recovery of knee joint in the 1st 24 h postoperative (number of patients who are capable to hold quadriceps muscle > 5 s in 1st 24 h degree of knee maximum active flexion and extension, 2 min walk test, time up and go (TUG) score) and patients’ satisfaction.MethodsSixty-three patients listed for elective TKA in this prospective single-blind, controlled study were randomly assigned into three equal groups. The Control (C) group received standard analgesia (1 g/8hrs paracetamol plus 15 mg/24hrs meloxicam). The GNB group received GNB block with 2.5 ml of 0.5% bupivacaine injected into each target point. The Combination group received GNB block + IPACK block (with 15 ml bupivacaine 0.5% injected). All patients received spinal anesthesia. Rescue analgesia was administered as 3 mg of intravenous morphine to the patient whose visual analogue scale (VAS) score was ≥ 4. The postoperative pain management protocol regimen for all patients in the three groups was administration of intravenous 30 mg ketorolac every 6 h postoperatively not exceeding 120 mg/day.ResultsThe combination group demonstrated significantly the lowest VAS pain scores at 2 h, 4 h, 6 h, 8 h, 18 h and 24 h except at 12 h postoperatively during both rest and mobility compared with other groups. However, the GNB group showed significant lower pain scores at the same measured time points except at 8 h postoperatively compared to control group (p < 0.0001). The time to the first request for rescue analgesia was significantly longer in the combination and GNB groups compared to control group, with the longest duration in the combination group (median 13.5 h, IQR 13-22.7 vs. 8.5 h, IQR 8–9 in GNB, and 3 h, IQR 2–4 h in control; p < 0.0001). Morphine consumption within the first 24 h postoperatively was significantly reduced among groups, being lowest in the combination group (median 3 mg) and highest in the control group (median 9 mg; p < 0.0001). The Combination group demonstrated significantly the best functional rehabilitation of the knee joint at 24hs postoperatively.ConclusionIn patients undergoing Total knee arthroplasty, adding IPACK block to GNB provides the best optimal analgesia and enhancing recovery compared to GNB alone.Institutional review board approvalIRB#: 9577/19-9-2022Trial registrationClinicalTrials.gov NCT05672784.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12871-025-03408-0. Background Total knee arthroplasty (TKA) is a commonly used surgical intervention for the treatment of joint immobility and debilitating pain characteristic of chronic knee osteoarthritis (OA) [1]. It has been assumed that the rate of TKA will reach 3.48 million/year by 2030 [2]. This substantial increase in demand underscores the critical importance of optimizing TKA outcomes, including patient satisfaction, functional recovery, and long-term implant survival. Postoperative pain after TKA is considered a challenge for anesthesiologists as most of these patients experience intense pain following surgery [3]. Recently, genicular nerve block (GNB) has been reported as a novel therapeutic approach to alleviate both chronic knee pain and postoperative pain in TKA and offer adequate analgesia for the anterior, superolateral, and medial aspects of the knee [4]. GNB has been documented to decrease postoperative pain scores by selectively blocking the articular branch of the anterior capsule of the knee, and significantly reducing complications of high dose of local anesthetic solutions compared to local infiltration analgesia [5, 6]. Unfortunately, the analgesia provided by GNB does not involve the posterior capsule of the knee, which is innervated by the posterior branch of the obturator nerve, tibial nerve, and common peroneal nerve [7]. Infiltration between the popliteal artery and capsule of the posterior knee (IPACK) block is a relatively new regional anesthesia technique that delivers analgesia to the posterior compartment of the knee without any motor weakness affecting ambulation [3]. The present study hypothesized that in patients undergoing TKA under spinal anesthesia, the combination of IPACK and GNB would lower VAS pain scores, time to first call of rescue analgesia, total morphine consumption and enhanced recovery postoperatively compared to GNB alone. Methods This study was designed as a prospective, randomized, single-blinded controlled clinical trial. It received approval from the Institutional Review Board [IRB number: 9577/19-9-2022] and was registered on ClinicalTrials.gov [NCT05672784] on November 5th, 2022. All participants voluntarily enrolled in the study after providing written informed consent. All work was carried out in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration, 2014 [8]. The first patient was enrolled on 15th November 2022. The study included 63 adult patients aged 21–65 years who underwent elective TKA under spinal anesthesia. Patients were ASA I or II according to the American Society of Anesthesiologists classification and both genders were included. Patients with a history of allergy to either local anesthesia or opioid analgesics, acute decompensated heart failure, peripheral vascular disease, heart block, hypertension, coronary disease, bleeding disorders, asthma, compromised renal or hepatic function, pregnancy, or those taking anticoagulant, anti-platelet, or B blocker medications were excluded. Randomization and patients’ allocation Using computer-generated random numbers, each patient was assigned a unique number. The patient was allocated to a group according to this number. The number was placed in a sealed, concealed envelope that was opened on the day of surgery by an independent anesthesiologist who was not involved in other study steps regarding performing the block and collecting the data. Outcome assessors were blinded to treatment allocation. Participation in the study was voluntary, and patients could withdraw from the study at any time without affecting their medical or surgical care. Anesthetic management The preoperative visit occurred the night before surgery to obtain a complete medical history, evaluate the patient’s medical condition and drug allergies, and describe the anesthesia plan and fasting guidelines [6 h for solid foods and 2 h for liquids]. In the operating room, patients were monitored with standard monitoring equipment [pulse oximetry, Electrocardiogram (ECG), and non-invasive blood pressure]. An intravenous line was inserted using a wide-bore cannula [14 gauges] before administering 3–5 mg of midazolam intravenously for sedation before surgery and for nerve blocks, a prophylactic antibiotic, and initiating an infusion of 10 mL/kg of lactated ringer’s solution. According to the computer-generated random numbers, the patients were allocated into three equal groups: C Group [control group]: Received the standard analgesia with 1 g of paracetamol every 8 h and 15 mg of meloxicam every 24 h. GNB group Received GNB block. Combination group Received GNB block plus IPACK block. GNB block: GNB block: GNB block: In the supine position with a pillow placed below the popliteal fossa, a 10 MHz linear transducer (GE Ultrasound Korea, Ltd) was placed parallel to the long bones of the legs (femur, tibia). The target points were adjacent to the superior lateral and medial, and inferior medial genicular arteries to block the superior lateral and medial, and inferior medial branches of genicular nerve, respectively. Identification of the arteries was made using color Doppler near the periosteal regions (the junctions of the epicondyle and the bodies of the tibia and femur, accordingly). Needle insertion was performed in the plane of the ultrasound probe in the long-axis view [9]. After ensuring that the needle tip was positioned adjacent to the genicular arteries, 2.5 ml of 0.5% bupivacaine was injected at each target point [Video 1]. IPACK block: IPACK block: IPACK block: The IPACK block was administered with the patient positioned supine and the knee flexed at a 45-degree angle. A curved, low-frequency ultrasound probe was placed transversely over the popliteal fossa, 2–3 cm above the patella. The transducer was then slid proximally and distally to identify the distal part of the femur’s shaft and the popliteal artery. [If the femoral condyles appear first, the probe was slid proximally until the humps of the femoral condyles disappeared of and the flat metaphysis appeared]. At this level, a 22-G spinal needle was advanced using an in-plane technique from an anteromedial to posterolateral direction between the femur and the popliteal artery until the needle tip was 1 cm beyond the lateral edge of the popliteal artery [10]. Subsequently, 15 ml of 0.5% bupivacaine was injected in small, even doses while slowly withdrawing the needle. All procedures were performed under strict aseptic condition [Video 2]. Anesthesia for the TKA was provided by spinal anesthesia administered in the sitting position at the L3/4 level using a 25-G x 3.5-inch spinal needle. A 12.5 mg of hyperbaric bupivacaine 0.5% was injected. Anesthesia for the TKA was provided by spinal anesthesia administered in the sitting position at the L3/4 level using a 25-G x 3.5-inch spinal needle. A 12.5 mg of hyperbaric bupivacaine 0.5% was injected. Anesthesia for the TKA was provided by spinal anesthesia administered in the sitting position at the L3/4 level using a 25-G x 3.5-inch spinal needle. A 12.5 mg of hyperbaric bupivacaine 0.5% was injected. Postoperative Recovery from spinal anesthesia was assessed using the Bromage score [11] (0: no motor block at all; 1: inability to raise the extended knee but able to move the knee and feet; 2: inability to raise the extended knee or move the knee but able to move the feet; 3: complete block of motor function in the limb). Recovery from spinal anesthesia was assessed using the Bromage score [11] (0: no motor block at all; 1: inability to raise the extended knee but able to move the knee and feet; 2: inability to raise the extended knee or move the knee but able to move the feet; 3: complete block of motor function in the limb). Recovery from spinal anesthesia was assessed using the Bromage score [11] (0: no motor block at all; 1: inability to raise the extended knee but able to move the knee and feet; 2: inability to raise the extended knee or move the knee but able to move the feet; 3: complete block of motor function in the limb). Patients were allowed to walk soon after recovery of motor function with the assistance of a standard adult walker and the ward nursing team. Patients were allowed to walk soon after recovery of motor function with the assistance of a standard adult walker and the ward nursing team. Patients were allowed to walk soon after recovery of motor function with the assistance of a standard adult walker and the ward nursing team. Rescue analgesia was administered as 3 mg of intravenous morphine to the patient whose Visual analogue scale (VAS) score was ≥ 4. The postoperative pain management protocol regimen for all patients in the three groups was administration of intravenous 30 mg ketorolac every 6 h postoperatively not exceeding 120 mg/day. Rescue analgesia was administered as 3 mg of intravenous morphine to the patient whose Visual analogue scale (VAS) score was ≥ 4. The postoperative pain management protocol regimen for all patients in the three groups was administration of intravenous 30 mg ketorolac every 6 h postoperatively not exceeding 120 mg/day. Rescue analgesia was administered as 3 mg of intravenous morphine to the patient whose Visual analogue scale (VAS) score was ≥ 4. The postoperative pain management protocol regimen for all patients in the three groups was administration of intravenous 30 mg ketorolac every 6 h postoperatively not exceeding 120 mg/day. The primary outcome was VAS scores at 8 hours with mobility postoperative. Pain intensity was measured using VAS scale described as “a 10-cm horizontal line with two ends, one end indicating no pain [0] and the other end indicating the worst imaginable pain [10] “. Patients were asked to mark a point on the line that corresponded to their pain intensity [12]. The Secondary outcomes included: Pain intensity at 2,4,6,12,24 h postoperative at rest and motion, time to the first dose of rescue analgesia [morphine] [VAS ≥ 4] after the end of surgery, total morphine consumption within 24 h postoperatively. Functional rehabilitation of the knee assessed at 24 h postoperatively including: Degree of maximum active extension and flexion of the knee, 2-min walk test [the distance walked by patients in meters within 2 min], time up and go [TUG] score [the time taken in sec for a patient to rise from a standard chair, walk three meters, turn around, return back to the chair, and sit down], and number of patients capable of holding the quadriceps muscle for longer than 5 s. Postoperative patient satisfaction assessed using a 5-point Likert scale [13], in which 5: indicates very satisfied 4: indicates satisfied 3: indicates neither satisfied nor dissatisfied 2: indicates dissatisfied 1: indicates very dissatisfied. Statistical analysis Assuming large effect of genicular with IPACK blocks on reduce VAS at 8 h postoperative during mobility among patients. A sample size was calculated based on a 95% confidence level and power of 80%., using Cohen’s d effect size of 0.8 using G*Power software, version 3.1.9.7, a drop rate of nearly 20%, total sample size estimated 69 patients,23 patients per group.All data were collected, tabulated and statistically analyzed using (IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.2015. The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. Descriptive statistics for Quantitative variables were presented as the mean ± standard deviation and median values with interquartile ranges (Q1, Q3) for non-normally distributed data. Anova test (f) was used to compare between more than two groups of normally distributed variables. We analyzed prespecified individual postoperative time points (2, 4, 6, 8, 12, 18, and 24 h), as these represent clinically relevant decision-making intervals for postoperative analgesia management, rather than overall trajectories. We controlled for multiplicity using Bonferroni across time-point comparisons. Kruskall Wallius test (K) was used to compare between more than two groups of not normally distributed variables. If K test significant Mann Whitney u test was used for each pairwise to define significant group. Percent of categorical variables were compared using Pearson’s chi-square. All tests were two sided.P-value < 0.05 was considered statistically significant. The results were analyzed using per-protocol analysis. Assuming large effect of genicular with IPACK blocks on reduce VAS at 8 h postoperative during mobility among patients. A sample size was calculated based on a 95% confidence level and power of 80%., using Cohen’s d effect size of 0.8 using G*Power software, version 3.1.9.7, a drop rate of nearly 20%, total sample size estimated 69 patients,23 patients per group. Assuming large effect of genicular with IPACK blocks on reduce VAS at 8 h postoperative during mobility among patients. A sample size was calculated based on a 95% confidence level and power of 80%., using Cohen’s d effect size of 0.8 using G*Power software, version 3.1.9.7, a drop rate of nearly 20%, total sample size estimated 69 patients,23 patients per group. All data were collected, tabulated and statistically analyzed using (IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.2015. The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. Descriptive statistics for Quantitative variables were presented as the mean ± standard deviation and median values with interquartile ranges (Q1, Q3) for non-normally distributed data. Anova test (f) was used to compare between more than two groups of normally distributed variables. We analyzed prespecified individual postoperative time points (2, 4, 6, 8, 12, 18, and 24 h), as these represent clinically relevant decision-making intervals for postoperative analgesia management, rather than overall trajectories. We controlled for multiplicity using Bonferroni across time-point comparisons. Kruskall Wallius test (K) was used to compare between more than two groups of not normally distributed variables. If K test significant Mann Whitney u test was used for each pairwise to define significant group. Percent of categorical variables were compared using Pearson’s chi-square. All tests were two sided.P-value < 0.05 was considered statistically significant. The results were analyzed using per-protocol analysis. All data were collected, tabulated and statistically analyzed using (IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.2015. The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. Descriptive statistics for Quantitative variables were presented as the mean ± standard deviation and median values with interquartile ranges (Q1, Q3) for non-normally distributed data. Anova test (f) was used to compare between more than two groups of normally distributed variables. We analyzed prespecified individual postoperative time points (2, 4, 6, 8, 12, 18, and 24 h), as these represent clinically relevant decision-making intervals for postoperative analgesia management, rather than overall trajectories. We controlled for multiplicity using Bonferroni across time-point comparisons. Kruskall Wallius test (K) was used to compare between more than two groups of not normally distributed variables. If K test significant Mann Whitney u test was used for each pairwise to define significant group. Percent of categorical variables were compared using Pearson’s chi-square. All tests were two sided.P-value < 0.05 was considered statistically significant. The results were analyzed using per-protocol analysis. Result Of the 70 participants assessed for eligibility, 63 participants were enrolled and randomly divided into three equal groups (21 patients each) (Fig. 1). The age, weight, height, gender, ASA physical status (I and II), and the duration of surgery were comparable among the three patient groups (p ≥ 0.05) (Table 1).Fig. 1CONSORT study flowchart CONSORT study flowchart Table 1Baseline patient characteristics and duration of surgery by groupVariablesC Group(N = 21)GNB Group (N = 21)Combination Group(N = 21)Age (yr.)57.71 ± 9.7756.86 ± 9.6058.19 ± 8.82Weight (kg)79.19 ± 5.4476.14 ± 7.4278.14 ± 6.32Height (cm)167 ± 8.09168.9 ± 9.77169.5 ± 10.08Gender F/M7/14(33.33/66.67)9/12(42.86/57.14)10/11(47.62/52.38)ASA-PS (I/II)11/10(52.38/47.62)8/13(38.10/61.90)9/12(42.86/57.14)Duration of surgery(min)156.24 ± 10.24157.24 ± 9.86156.43 ± 8.56Values are presented as Number (%) for non-normally distributed variables or mean ± SD for normally distributed variablesSD Standard deviation, ASA-PS The American Society of Anesthesiologists physical status Table 1Baseline patient characteristics and duration of surgery by groupVariablesC Group(N = 21)GNB Group (N = 21)Combination Group(N = 21)Age (yr.)57.71 ± 9.7756.86 ± 9.6058.19 ± 8.82Weight (kg)79.19 ± 5.4476.14 ± 7.4278.14 ± 6.32Height (cm)167 ± 8.09168.9 ± 9.77169.5 ± 10.08Gender F/M7/14(33.33/66.67)9/12(42.86/57.14)10/11(47.62/52.38)ASA-PS (I/II)11/10(52.38/47.62)8/13(38.10/61.90)9/12(42.86/57.14)Duration of surgery(min)156.24 ± 10.24157.24 ± 9.86156.43 ± 8.56Values are presented as Number (%) for non-normally distributed variables or mean ± SD for normally distributed variablesSD Standard deviation, ASA-PS The American Society of Anesthesiologists physical status Baseline patient characteristics and duration of surgery by group Values are presented as Number (%) for non-normally distributed variables or mean ± SD for normally distributed variables SD Standard deviation, ASA-PS The American Society of Anesthesiologists physical status The combination group showed statistically significant lower pain intensity scores using Visual Analogue Scale (VAS) at all measured time points except at 12 h postoperatively during rest and mobility compared to GNB group (p < 0.0001). The combination group showed statistically significant lower pain intensity scores at all time points during rest and mobility compared to control group (p < 0.0001). The GNB group showed statistically significant lowest pain intensity scores at all the time points except at 8 h compared to other groups (p < 0.0001) (Tables 2 and 3). Table 2Visual analogue scale (VAS) scores at rest by group at different time pointsVAS at restControl group(n = 21)GNB group(n = 21)Combination group(n = 21)Kp-valueBasal VAS5(5–6)6(5–6)5(5–6)0.4080.6672 h3(2–5)0(0–0)0(0–0)51.4080.0001*,^4 h4(2–5)1(0–1)0(0–0)44.7700.0001 *,^,$6 h1(0–2)1(1–2)1(0–1)12.0510.002^,$8 h2(1–3)4(3–5)2(1–2)24.4900.0001*,$12 h4(4–5)0(0–1)4(2–4)36.7090.0001 *,^,$18 h3(2–3)2(1–4)0(0–2)15.7730.0001^,$24 h4(3–4)2(0–3)1(1–2)21.1050.0001*,^Values are presented as median, IQR: Interquartile Range for non-normally distributed variables, The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. K: Kruskall wallius test. Pairwise post-hoc tests. VAS = visual analogue scale scores. p ≥ 0.05 was considered no significant, p < 0.05 was considered significant*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Table 2Visual analogue scale (VAS) scores at rest by group at different time pointsVAS at restControl group(n = 21)GNB group(n = 21)Combination group(n = 21)Kp-valueBasal VAS5(5–6)6(5–6)5(5–6)0.4080.6672 h3(2–5)0(0–0)0(0–0)51.4080.0001*,^4 h4(2–5)1(0–1)0(0–0)44.7700.0001 *,^,$6 h1(0–2)1(1–2)1(0–1)12.0510.002^,$8 h2(1–3)4(3–5)2(1–2)24.4900.0001*,$12 h4(4–5)0(0–1)4(2–4)36.7090.0001 *,^,$18 h3(2–3)2(1–4)0(0–2)15.7730.0001^,$24 h4(3–4)2(0–3)1(1–2)21.1050.0001*,^Values are presented as median, IQR: Interquartile Range for non-normally distributed variables, The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. K: Kruskall wallius test. Pairwise post-hoc tests. VAS = visual analogue scale scores. p ≥ 0.05 was considered no significant, p < 0.05 was considered significant*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Visual analogue scale (VAS) scores at rest by group at different time points Values are presented as median, IQR: Interquartile Range for non-normally distributed variables, The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. K: Kruskall wallius test. Pairwise post-hoc tests. VAS = visual analogue scale scores. p ≥ 0.05 was considered no significant, p < 0.05 was considered significant *P < 0.05 for comparison control group with GNB group ^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group Table 3Visual analogue scale (VAS) scores during mobility by group at different time pointsVAS during mobilityC group(n = 21)GNB group(n = 21)Combination group(n = 21)Kp-valuebasal VAS6(6–7)6(6–7)6(6–7)0.9180.4052 h3(2–5)0(0–0)0(0–0)51.4810.0001*,^4 h5(3–5)1(0–1)0(0–1)44.0310.0001*,^6 h2(2–3)3(2–3)1(1–2)17.3640.0001^,$8 h3(3–3)5(3–6)2(2–3)21.5070.0001*,^,$12 h5(4–5)1(0–2)4(3–5)35.4440.0001*,$18 h2(2–3)2(2–4)3(2–3)0.5250.76924 h4(3–4)2(1–4)2(2–3)9.6770.008*.^Values are presented as median, IQR: Interquartile Range for non-normally distributed variables, The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. K: Kruskall wallius test. Pairwise post-hoc tests. VAS = visual analogue scale scores. p ≥ 0.05 was considered no significant, p < 0.05 was considered significant*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Table 3Visual analogue scale (VAS) scores during mobility by group at different time pointsVAS during mobilityC group(n = 21)GNB group(n = 21)Combination group(n = 21)Kp-valuebasal VAS6(6–7)6(6–7)6(6–7)0.9180.4052 h3(2–5)0(0–0)0(0–0)51.4810.0001*,^4 h5(3–5)1(0–1)0(0–1)44.0310.0001*,^6 h2(2–3)3(2–3)1(1–2)17.3640.0001^,$8 h3(3–3)5(3–6)2(2–3)21.5070.0001*,^,$12 h5(4–5)1(0–2)4(3–5)35.4440.0001*,$18 h2(2–3)2(2–4)3(2–3)0.5250.76924 h4(3–4)2(1–4)2(2–3)9.6770.008*.^Values are presented as median, IQR: Interquartile Range for non-normally distributed variables, The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. K: Kruskall wallius test. Pairwise post-hoc tests. VAS = visual analogue scale scores. p ≥ 0.05 was considered no significant, p < 0.05 was considered significant*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Visual analogue scale (VAS) scores during mobility by group at different time points Values are presented as median, IQR: Interquartile Range for non-normally distributed variables, The Shapiro Wilk test was used to detect the normality distribution of the Quantitative variables. K: Kruskall wallius test. Pairwise post-hoc tests. VAS = visual analogue scale scores. p ≥ 0.05 was considered no significant, p < 0.05 was considered significant *P < 0.05 for comparison control group with GNB group ^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group The median duration to first rescue analgesia (morphine) was statistically significantly longest in the combination group 13.5(13–22.7.7) h compared to 8.5(8–9) h in the GNB group and 3(2–4) h in the control group (p < 0.0001). The total 24-hour morphine consumption postoperatively was significantly lowest in the combination group 3(3–3) mg compared to 6(6–6) mg in the GNB group and 9(6–9) mg in the control group (p < 0.0001) (Table 4). Table 4Analgesic properties by groupVariablesC group(n = 21)GNB group(n = 21)combination group(n = 21)Kp-valuePostoperative time 1 st rescue of analgesia (h)3(2–4)8.5(8–9)13.5(13–22.7.7)31.2360.0001*,^,$Total morphine consumption (mg) at 1 st 24 h9(6–9)6(6–6)3(3–3)17.7560.0001*,^,$Values were presented as median (Q1- Q3) for non-normally distributed variables, K :{Kruskall wallius test]. P-value for Kruskall wallius test *P < 0.05 for control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Table 4Analgesic properties by groupVariablesC group(n = 21)GNB group(n = 21)combination group(n = 21)Kp-valuePostoperative time 1 st rescue of analgesia (h)3(2–4)8.5(8–9)13.5(13–22.7.7)31.2360.0001*,^,$Total morphine consumption (mg) at 1 st 24 h9(6–9)6(6–6)3(3–3)17.7560.0001*,^,$Values were presented as median (Q1- Q3) for non-normally distributed variables, K :{Kruskall wallius test]. P-value for Kruskall wallius test *P < 0.05 for control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Analgesic properties by group Values were presented as median (Q1- Q3) for non-normally distributed variables, K :{Kruskall wallius test]. P-value for Kruskall wallius test *P < 0.05 for control group with GNB group ^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group Regarding muscle strength, the number of patients who could hold the quadriceps muscle for more than 5 s at 24 h after surgery was significantly highest in the combination group (19 patients) compared to the GNB group (13 patients) and the control group (6 patients) (p < 0.0001). Knee range of motion at first 24 h postoperatively was significantly improved in the combination group compared to the other two groups (as demonstrated by higher degrees of maximum active flexion and lower degrees of maximum active extension). Moreover, the number of meters walked in the 2-min walk test was significantly highest, and the time taken for the Timed Up and Go test was significantly lowest in the combination group compared to the other two groups (p < 0.0001) (Table 5). Table 5Functional recovery of knee joint in the 1 st day after the surgery by groupVariablesControl groupN = 21GNB groupN = 21combination groupN = 21fp-valueNumber of patients hold quadriceps tension > 5 second6(38.6)13(61.9)19(90.5)16.8c0.0001*,^,$Maximum active flexion (degree)70.71 ± 9.9580.81 ± 14.1792.57 ± 13.4915.650.0001*,^,$Active knee extension (degree)4.048 ± 0.742.9 ± 0.941.71 ± 1.1930.20.0001*,^,$Two minutes-walk test (meters)6.95 ± 1.989.86 ± 2.2312.81 ± 1.8143.440.0001*,^,$Time up & go (seconds)59.28 ± 4.7851.86 ± 4.2843.3 ± 2.5684.020.0001*,^,$Values are presented as Number (%) for non-normally distributed variables or mean ± SD for normally distributed variables. SD = standard deviation, F:anova test, χ 2 Chi-square test[c]. p ≥ 0.05 was considered insignificant*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group Table 5Functional recovery of knee joint in the 1 st day after the surgery by groupVariablesControl groupN = 21GNB groupN = 21combination groupN = 21fp-valueNumber of patients hold quadriceps tension > 5 second6(38.6)13(61.9)19(90.5)16.8c0.0001*,^,$Maximum active flexion (degree)70.71 ± 9.9580.81 ± 14.1792.57 ± 13.4915.650.0001*,^,$Active knee extension (degree)4.048 ± 0.742.9 ± 0.941.71 ± 1.1930.20.0001*,^,$Two minutes-walk test (meters)6.95 ± 1.989.86 ± 2.2312.81 ± 1.8143.440.0001*,^,$Time up & go (seconds)59.28 ± 4.7851.86 ± 4.2843.3 ± 2.5684.020.0001*,^,$Values are presented as Number (%) for non-normally distributed variables or mean ± SD for normally distributed variables. SD = standard deviation, F:anova test, χ 2 Chi-square test[c]. p ≥ 0.05 was considered insignificant*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group Functional recovery of knee joint in the 1 st day after the surgery by group Values are presented as Number (%) for non-normally distributed variables or mean ± SD for normally distributed variables. SD = standard deviation, F:anova test, χ 2 Chi-square test[c]. p ≥ 0.05 was considered insignificant *P < 0.05 for comparison control group with GNB group ^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group Regarding patient satisfaction scores, assessed using a 5-point Likert scale, the combination group showed statistically significantly higher scores compared to the other two groups (Table 6). Table 6Patients’ satisfaction by groupPatients’ satisfactionControl group(n = 21)GNB group(n = 21)Combination group(n = 21)χ 2p-value1 = Not at all satisfied13(61.90)0.00.032.760.0001*,^2 = Not satisfied6(28.57)9(42.86)0.011.030.004^,$3 = Not sure2(9.52)4(19.05)5(23.81)1.540.464 = Satisfied0.08(38.09)5(23.81)9.4980.008*,^5 = Very satisfied0.00.011(52.38)26.650.0001^,$Values are presented as Number (%) for non-normally distributed variables, χ 2 Chisquare test. p-value for χ2 Chisquare test*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Table 6Patients’ satisfaction by groupPatients’ satisfactionControl group(n = 21)GNB group(n = 21)Combination group(n = 21)χ 2p-value1 = Not at all satisfied13(61.90)0.00.032.760.0001*,^2 = Not satisfied6(28.57)9(42.86)0.011.030.004^,$3 = Not sure2(9.52)4(19.05)5(23.81)1.540.464 = Satisfied0.08(38.09)5(23.81)9.4980.008*,^5 = Very satisfied0.00.011(52.38)26.650.0001^,$Values are presented as Number (%) for non-normally distributed variables, χ 2 Chisquare test. p-value for χ2 Chisquare test*P < 0.05 for comparison control group with GNB group^P < 0.05 for comparison control with combination group$P < 0.05 for comparison GNB group with combination group Patients’ satisfaction by group Values are presented as Number (%) for non-normally distributed variables, χ 2 Chisquare test. p-value for χ2 Chisquare test *P < 0.05 for comparison control group with GNB group ^P < 0.05 for comparison control with combination group $P < 0.05 for comparison GNB group with combination group No adverse effects were observed during the 24-h observation window. Discussion The present study revealed that the ultrasound guided combination of IPACK and GNB provides the best optimal analgesic regimen for pain relief after TKA under spinal anesthesia in comparison to GNB alone. This is the first randomized controlled trial directly comparing GNB vs. GNB + IPACK in TKA. Recently, care of patients undergoing successful knee arthroplasty has shifted to early ambulation and discharge. This is facilitated by motor‑sparing nerve blocks [14]. Analgesia promoted by motor-sparing techniques has been evaluated in numerous studies while there is a paucity of literature discussing the combination of this motor sparing technique to determine the optimal regimen for TKA [15]. In the current study, the combination group showed significantly decreased pain intensity scores using VAS up to 12 h postoperatively during rest and mobility compared to up to 8 h in the GNB group. Consistent with the present study results, Donghai et al. [16] reported longer analgesic duration, lower pain scores and less morphine consumption when IPACK block added to adductor canal block. Rambhia et al. [17] reported lower Pain scores in the GNB group at the 6 h time point compared to the SHAM group. However, Eid et al. [18] in their study reported that the time concerning GNB was ranged between 10 and 12 h. The advantages of combining GNB and IPACK block in the present study compared to other knee joint pain management studies are enhanced analgesic efficacy, decrease postoperative morphine consumption, and improved functional measures [19–21]. Moreover, GNB covers all articular sensory nerves of the knee compared to adductor canal block (ACB) [22]. The combination of GNB + IPACK resulted in lower opioid consumption due to the more effective analgesia provided by targeting the genicular nerves of the knee joint compared to femoral nerve block (FNB) that only targets the femoral nerve that covers the anterior thigh and knee and associated with weakness of quadriceps muscles hindering early mobility after total knee arthroplasty [23]. So, GNB block nociceptive pathways more effectively than FNB. These factors may have contributed to the observed difference in opioid consumption between GNB + IPACK and FNB + IPACK [24]. The median time for rescue analgesia in the combination group (GNB + IPACK) in the present study was significantly longer (13.5 h) compared to 8.5 h in the GNB group and 3 h in the control group. This aligns with previous studies that have shown prolonged analgesia time by adding an IPACK block in the setting of multimodal analgesia [25–28]. In the present study, patients in the combination group reportedly consumed only 3 mg of morphine in 24 h, compared to 6 mg in the GNB group and 9 mg in the control group. The relatively low morphine consumption values in this study can be attributed to the routine postoperative pain management regimen in our hospital, in addition to the use of rescue analgesics. Furthermore, all patients were anesthetized using spinal anesthesia, which delays postoperative sensory perception of pain. The relatively older mean age of the study population may also have played a role. However, the current study differs from the study by Sankineani et al. [24] in that it examines the combination of IPACK block with GNB for managing severe pain after TKA by incorporating rescue analgesia and total morphine consumption. Furthermore, the randomization in the current study provides additional strength compared to the study by Sankineani et al. [24]. The inclusion of intravenous morphine as rescue analgesia in the current study is a positive aspect when compared to the study by Tyfun et al. [26], which utilized tramadol. In a meta-analysis study [28] including thirteen randomized controlled trials including 1347 knees, IPACK blocks when added to multimodal analgesia was associated with a significant reduction in rest and ambulation pain scores. This was observed from 2 h and up to one week postoperative. IPACK also reduced the sleep disturbance rate on Post-operative day 1 with reduction in postoperative morphine consumption from 24 to 48 h and decreased the rate of morphine requirements during the first 12 to 24 h. Previous literature reviews have shown that following knee arthroplasty, there is a 20 to 25% reduction in muscle function, a 51% delay in stair climbing speed, an 18% decrease in walking speed, as well as edema, discomfort, and hemorrhage that can restrict the range of motion of the knee joint [29–31]. In the present study, we did not observe any motor deficits in any of the genicular blocks or IPACK block, with preservation of quadriceps femoris strength [5, 6, 14]. This is an important indicator for evaluating motor function postoperatively in knee surgery [32]. The statistically significant higher number of patients who could hold the quadriceps muscle for more than 5 s with improved range of motion (the degree of maximum active flexion and extension) in the combination group compared to the other two groups in the current study in the first 24 h postoperative indicates better pain control, no motor deficits, and improved physical activity in this group. This finding is consistent with Dutta et al. [33], who concluded that early postoperative continuous passive motion, high velocity and intensity exercises, along with early rehabilitation, lead to better recovery and faster healing. As recommended by the American Academy of Orthopedic Surgeons, mobilization should be performed as soon as possible after total knee and hip arthroplasty [34]. Early mobilization can reduce the rate of deep vein thrombosis and shortens the length of hospital stay [35, 36]. Our findings revealed that the value of the 2-minute walk test was significantly greater while time up and go was significantly shorter in the combination group compared to the other two groups during the 1 st 24 h postoperatively. It has been documented that IPACK when combined with another type of block provided better postoperative pain control and significantly enhanced early ambulation and rehabilitation [37, 38]. In the current study, 11 patients (52.38%) were very satisfied and 5 (23.81%) patients were satisfied in combination group compared to no patient (0%) was very satisfied and only 8 (38.09%) patients were satisfied in GNB group (p = 0.0001 and 0.08 respectively). However, no patient was very satisfied or satisfied in control group. Patient satisfaction is considered as an important indicator for evaluating health care quality; it is also a good indicator of patients self-perceived health condition following surgery [39, 40]. Factors influencing satisfaction are variable and complex. These including proper pain control, treatment outcome in the term of recovery of physical activity and reduction of functional limitations [41, 42]. These were in agreement with the current study results that revealed statistically significant highest level of satisfaction in the combination group compared to other two groups. Limitation of the study The actual sample may reduce power at later time points and that per-protocol analysis can introduce optimism bias relative to intention- to- treat. The short follow-up period (24 h) and no functional assessment beyond basic movement and satisfaction may not be sufficient to compare the long-term effects of the blocks on chronic pain. The 24-h horizon constrains inference about persistent analgesia and later functional milestones. The lack of objective block confirmation did not affect our results, as both blocks were performed using ultrasound guidance. We used a single-blind design instead of a double-blind design, as the anesthesia used was spinal anesthesia. Additionally, there was a control group without the block. Future studies may be needed to evaluate ultrasound techniques, such as comparing classic three-point injections versus five-point injections with the addition of inferior lateral genicular nerve (ILGN) + recurrent peroneal nerve (RPN) block for genicular nerve block and proximal versus distal technique for IPACK block. Moreover, evaluating the effect of different concentrations and volumes of local anesthetics and using continuous infusion catheters for long-term pain relief should be considered. Another known limitation is that the genicular nerves do not have cutaneous sensory innervation unlike many peripheral nerve blocks, making traditional skin sensory testing unreliable. This means that it is not clinically feasible to confirm block success with standard methods so, the success of the block in the present study was assumed based on technique rather than verified by objective sensory testing. Conclusion Adding Infiltration between Popliteal Artery and Capsule of Posterior Knee block to genicular nerve block provides the best pain control and facilitates rehabilitation during the first 24 h after total knee arthroplasty under spinal anesthesia compared to genicular nerve block alone. This combination is recommended as an optimal multimodal analgesic technique for this type of orthopedic surgery. Supplementary Information Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3.